Cargando…
Revascularization for Left Main and Multivessel Coronary Artery Disease: Current Status and Future Prospects after the EXCEL and NOBLE Trials
Revascularization of severe left main and multivessel coronary artery disease has been shown to improve survival in both stable ischemic heart disease and acute coronary syndrome. While revascularization with coronary artery bypass surgery for these disease entities carries class I recommendation in...
Autores principales: | Al-Hijji, Mohammed, El Sabbagh, Abdallah, Holmes, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986745/ https://www.ncbi.nlm.nih.gov/pubmed/29856140 http://dx.doi.org/10.4070/kcj.2018.0078 |
Ejemplares similares
-
NOBLE and EXCEL: The debate for excellence in dealing with left main stenosis
por: Kindi, Hamood Al, et al.
Publicado: (2018) -
Understanding the role of coronary artery revascularization in patients with left ventricular dysfunction and multivessel disease
por: Acerbo, Vincenzo, et al.
Publicado: (2023) -
Revascularization and survival in multivessel coronary artery disease in ischemia
por: Maron, David J., et al.
Publicado: (2022) -
Hybrid coronary revascularization vs. percutaneous coronary interventions for multivessel coronary artery disease
por: Hannan, Edward L., et al.
Publicado: (2021) -
Multivessel spontaneous coronary artery dissection involving the left main coronary artery: a case report
por: Cepas-Guillén, Pedro L, et al.
Publicado: (2019)